Literature DB >> 28918879

Axitinib-related osteonecrosis of the jaw.

Vinod Patel1, Chris Sproat2, Jerry Kwok2, Nikki Tanna3.   

Abstract

Tyrosine kinase inhibitors (TKIs) are oral chemotherapy drugs used primarily to treat leukemias, renal cell carcinomas, gastrointestinal stromal tumors, and neuroendocrine tumors. Within this group, a number of drugs have already been implicated in jaw necrosis. Axitinib (Inlyta) is a novel TKI currently licensed for the treatment of renal cell carcinoma. We report the first case, to our knowledge, of jaw necrosis solely related to this medication and review the literature surrounding TKIs and their implication in osteonecrosis of the jaw.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28918879     DOI： 10.1016/j.oooo.2017.08.003

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  6 in total

1.  Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.

Authors:  Ourania Nicolatou-Galitis; Maria Kouri; Erofili Papadopoulou; Emmanouil Vardas; Dimitra Galiti; Joel B Epstein; Sharon Elad; Giuseppina Campisi; Nikolaos Tsoukalas; Kivanc Bektas-Kayhan; Winston Tan; Jean-Jacques Body; Cesar Migliorati; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2018-10-23       Impact factor: 3.603

Review 2.  Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature.

Authors:  Kununya Pimolbutr; Stephen Porter; Stefano Fedele
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

Review 3.  The impact of sex steroids on osteonecrosis of the jaw.

Authors:  Ranhee Kim; Sung Woo Kim; Hoon Kim; Seung-Yup Ku
Journal:  Osteoporos Sarcopenia       Date:  2022-06-17

Review 4.  Review and update on drugs related to the development of osteonecrosis of the jaw.

Authors:  A Eguia; L Bagán-Debón; F Cardona
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01

Review 5.  Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.

Authors:  Minerva Codruta Badescu; Elena Rezus; Manuela Ciocoiu; Oana Viola Badulescu; Lacramioara Ionela Butnariu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

Review 6.  Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates.

Authors:  L Lorusso; L Pieruzzi; M Gabriele; M Nisi; D Viola; E Molinaro; V Bottici; R Elisei; L Agate
Journal:  J Endocrinol Invest       Date:  2021-07-21       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.